LOAMU
DMK

Lombard Odier Asset Management (USA)’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-714
Closed -$260K – 269
2017
Q2 		$260K Buy
+714
New +$214K 0.02% 238
2015
Q4 		– Sell
-753
Closed -$208K – 199
2015
Q3 		$208K Buy
753
+39
+5% +$10.9K 0.02% 178
2015
Q2 		$210K Buy
+714
New +$216K 0.01% 187

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s DMK Position: Q3 2017 in Review

Lombard Odier Asset Management (USA) sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2017, closing a stake of 714 shares — an estimated $260K sold.

Lombard Odier Asset Management (USA) first reported a position in DMK in Q2 2015 and held it in 3 quarters. The position peaked at $260K in Q2 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q3 2017.

  • Lombard Odier Asset Management (USA) reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2017 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 714 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2017, an estimated $260K.
  • Lombard Odier Asset Management (USA) first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2015 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s DMK Pharmaceuticals Corporation Common Stock position peaked at $260K in Q2 2017.
  • 46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2017.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2017, filed 14 Nov 2017.